1. Home
  2. ATRC vs BAK Comparison

ATRC vs BAK Comparison

Compare ATRC & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • BAK
  • Stock Information
  • Founded
  • ATRC 2000
  • BAK 1972
  • Country
  • ATRC United States
  • BAK Brazil
  • Employees
  • ATRC N/A
  • BAK N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • BAK Major Chemicals
  • Sector
  • ATRC Health Care
  • BAK Industrials
  • Exchange
  • ATRC Nasdaq
  • BAK Nasdaq
  • Market Cap
  • ATRC 1.5B
  • BAK 1.6B
  • IPO Year
  • ATRC 2005
  • BAK N/A
  • Fundamental
  • Price
  • ATRC $33.75
  • BAK $4.09
  • Analyst Decision
  • ATRC Strong Buy
  • BAK Strong Buy
  • Analyst Count
  • ATRC 10
  • BAK 3
  • Target Price
  • ATRC $48.50
  • BAK $9.75
  • AVG Volume (30 Days)
  • ATRC 481.1K
  • BAK 952.8K
  • Earning Date
  • ATRC 04-29-2025
  • BAK 05-07-2025
  • Dividend Yield
  • ATRC N/A
  • BAK N/A
  • EPS Growth
  • ATRC N/A
  • BAK N/A
  • EPS
  • ATRC N/A
  • BAK N/A
  • Revenue
  • ATRC $465,307,000.00
  • BAK $12,516,128,020.00
  • Revenue This Year
  • ATRC $14.60
  • BAK $17.64
  • Revenue Next Year
  • ATRC $12.58
  • BAK $4.92
  • P/E Ratio
  • ATRC N/A
  • BAK N/A
  • Revenue Growth
  • ATRC 16.55
  • BAK 9.70
  • 52 Week Low
  • ATRC $18.94
  • BAK $2.85
  • 52 Week High
  • ATRC $43.11
  • BAK $9.21
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 53.13
  • BAK 61.91
  • Support Level
  • ATRC $30.78
  • BAK $3.27
  • Resistance Level
  • ATRC $34.23
  • BAK $4.13
  • Average True Range (ATR)
  • ATRC 1.97
  • BAK 0.23
  • MACD
  • ATRC 0.28
  • BAK 0.10
  • Stochastic Oscillator
  • ATRC 88.41
  • BAK 96.48

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About BAK Braskem SA ADR

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

Share on Social Networks: